Newborn Screening for Severe Combined Immunodeficiency: Analytic and Clinical Performance of the T Cell Receptor Excision Circle Assay in France (DEPISTREC Study)-Reference-Cited by-同舟云学术

Newborn Screening for Severe Combined Immunodeficiency: Analytic and Clinical Performance of the T Cell Receptor Excision Circle Assay in France (DEPISTREC Study)

Published:2018-09-24 Issue:7 Volume:38 Page:778-786
ISSN:0271-9142
Container-title:Journal of Clinical Immunology
language:en
Short-container-title:J Clin Immunol

Author:

Audrain Marie A. P.^ORCID,Léger Alexandra J. C.,Hémont Caroline A. F.,Mirallié Sophie M.,Cheillan David,Rimbert Marie G. M.,Le Thuaut Aurélie M-P.,Sébille-Rivain Véronique A.,Prat Aurore,Pinel Enora M. Q.,Divry Eléonore,Dert Cécile G. L.,Fournier Maxime A. G.,Thomas Caroline J. C.

Funder

Direction Générale de l’offre de Soins

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://link.springer.com/article/10.1007/s10875-018-0550-7/fulltext.html

Reference19 articles.

1. Buckley R, Schiff S, Schiff R, et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med. 1999;340:508–16.

2. Chan K, Puck JM. Development of a population-based screening for severe combined immunodeficiency. J Allergy Clin Immunol. 2005;115:391–8.

3. Puck JM, SCID Newborn Screening Working Group. Population-based newborn screening for severe combined immunodeficiency: steps toward implementation. J Allergy Clin Immunol. 2007;120:760–8.